z-logo
open-access-imgOpen Access
First real-world data from HANNA – a non-interventional study with nivolumab in patients with squamous cell carcinoma of the head and neck (SCCHN) in Germany
Author(s) -
Andreas Dietz,
Thomas Gauler,
E. von der Heyde,
Manfred Welslau
Publication year - 2019
Publication title -
laryngo-, rhino-, otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0039-1685977
Subject(s) - nivolumab , docetaxel , medicine , tolerability , cetuximab , oncology , head and neck cancer , head and neck squamous cell carcinoma , quality of life (healthcare) , head and neck , real world data , methotrexate , population , chemotherapy , radiation therapy , surgery , adverse effect , cancer , immunotherapy , nursing , colorectal cancer , data science , environmental health , computer science

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here